Rensselaer Polytechnic Institute and Icahn School of Medicine at Mount Sinai Announce Joint Center for Engineering and Precision Medicine

Rensselaer Polytechnic Institute

PR96249

 

NEW YORK, May 31, 2022 /PRNewswire=KYODO JBN/--

 

Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount

Sinai recently announced the creation of the Center for Engineering and

Precision Medicine (

https://c212.net/c/link/?t=0&l=en&o=3551088-1&h=818860422&u=https%3A%2F%2Fbiotech.rpi.edu%2Fpartners%2Ficahn-school-medicine-mount-sinai%2Finstitute-engineering-and-precision-medicine-iepm&a=Center+for+Engineering+and+Precision+Medicine

) (CEPM), one of the first centers in the nation to bridge engineering and

engineering science with medicine. This undertaking will build on shared basic

research discoveries, explore unique therapeutic innovations in cancer,

Alzheimer's, tissue degeneration, and infectious diseases; educate a new

generation of biomedical leaders; and develop new technologies and processes

that enhance patient outcomes in unprecedented ways. CEPM represents an

evolution in the successful partnership between Mount Sinai and RPI.

 

Photo -

https://mma.prnewswire.com/media/1828036/Rensselaer_Polytechnic_Institute_New_Center.jpg

 

 

The center at 619 West 54th Street in Manhattan will drive advances in

point-of-care and point-of-use devices and diagnostics; microphysiological

platforms for discovery and diagnosis; robotic surgery; biomedical imaging;

therapeutics biomanufacturing; and artificial intelligence and machine learning

applied to biomedical data. These engineering advances will improve patients'

quality of life by synergizing state-of-the-art expertise in research and

education at the nexus of engineering and medicine.

 

"This transformative partnership between Rensselaer and Icahn Mount Sinai

recognizes that engineering and engineering science is fundamental to the

understanding of biomedical phenomena and is essential to the development of

the next generation of precision diagnostics and therapeutics, human health and

well-being, and to the training of advanced researchers and physicians," said

Shirley Ann Jackson, PhD (

https://c212.net/c/link/?t=0&l=en&o=3551088-1&h=2409599113&u=https%3A%2F%2Fpresident.rpi.edu%2Fpresident-biography&a=Shirley+Ann+Jackson%2C+PhD

), President of Rensselaer Polytechnic Institute. "Innovative research is a

foundation of Rensselaer, as our students, faculty, and graduates continue to

change the world through scientific and technological advances. This center

will continue to fuel medical and scientific discoveries with life-changing

impacts across the globe."

 

"From highly sensitive and accurate bioimaging systems to new drug target

discoveries, the major inventions that have shaped modern medicine were born

out of close collaboration between engineers and clinicians," said Dennis S.

Charney, MD (

https://c212.net/c/link/?t=0&l=en&o=3551088-1&h=2793762413&u=https%3A%2F%2Ficahn.mssm.edu%2Fprofiles%2Fdennis-s-charney&a=Dennis+S.+Charney%2C+MD

), Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai

and President for Academic Affairs of the Mount Sinai Health System. "The CEPM

presents a bold new paradigm for that collaboration to continue that we believe

will result in unprecedented advances in science, medicine, and human health.

In addition, the PhD program will enable us to attract and equip a new

generation of researchers with the interdisciplinary engineering and clinical

skills to pursue more groundbreaking, impactful research."

 

Contact: Deanna Cohen, cohend8@rpi.edu, +1-518-233-4828

 

SOURCE:  Rensselaer Polytechnic Institute

 

 

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中